Literature DB >> 32255491

ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19.

Rhian M Touyz1, Hongliang Li2, Christian Delles1.   

Abstract

Angiotensin converting enzyme 2 (ACE2) is the major enzyme responsible for conversion of Ang II into Ang-(1-7). It also acts as the receptor for severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2, which causes Coronavirus Disease (COVID)-19. In recognition of the importance of ACE2 and to celebrate 20 years since its discovery, the journal will publish a focused issue on the basic science and (patho)physiological role of this multifunctional protein.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  ACE2 receptor; Angiotensin; COVID-19; cardiovascular; coronavirus; hypertension

Mesh:

Substances:

Year:  2020        PMID: 32255491     DOI: 10.1042/CS20200363

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  17 in total

Review 1.  Pregnancy, Preeclampsia, and COVID-19: Susceptibility and Mechanisms: A Review Study.

Authors:  Babak Sayad; Zeinab Mohseni Afshar; Feizollah Mansouri; Mehdi Salimi; Ronak Miladi; Somayeh Rahimi; Zohreh Rahimi; Maria Shirvani
Journal:  Int J Fertil Steril       Date:  2022-05-08

2.  Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex.

Authors:  Alberto Bartolomé; Jiani Liang; Pengfei Wang; David D Ho; Utpal B Pajvani
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 3.  Coronary microvascular dysfunction pathophysiology in COVID-19.

Authors:  Jie Yin; Shaoshen Wang; Yang Liu; Junhong Chen; Dongye Li; Tongda Xu
Journal:  Microcirculation       Date:  2021-06-02       Impact factor: 2.679

Review 4.  Covid-19: the renin-angiotensin system imbalance hypothesis.

Authors:  Katharina Lanza; Lucas G Perez; Larissa B Costa; Thiago M Cordeiro; Vitria A Palmeira; Victor T Ribeiro; Ana Cristina Simões E Silva
Journal:  Clin Sci (Lond)       Date:  2020-06-12       Impact factor: 6.124

Review 5.  Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.

Authors:  Celestino Sardu; Jessica Gambardella; Marco Bruno Morelli; Xujun Wang; Raffaele Marfella; Gaetano Santulli
Journal:  J Clin Med       Date:  2020-05-11       Impact factor: 4.241

Review 6.  COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation.

Authors:  Ioannis Zabetakis; Ronan Lordan; Catherine Norton; Alexandros Tsoupras
Journal:  Nutrients       Date:  2020-05-19       Impact factor: 5.717

7.  Neurological manifestations in COVID-19 and its possible mechanism.

Authors:  Xiaojia Tang; Yuhan Luo; Yuxia Song; Hongyang Fan; Sisi Dong; Peipei Liu; Yingzhu Chen
Journal:  Aging (Albany NY)       Date:  2020-09-27       Impact factor: 5.955

Review 8.  Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19.

Authors:  Rhian M Touyz; Marcus O E Boyd; Tomasz Guzik; Sandosh Padmanabhan; Linsay McCallum; Christian Delles; Patrick B Mark; John R Petrie; Francisco Rios; Augusto C Montezano; Robert Sykes; Colin Berry
Journal:  CJC Open       Date:  2021-06-16

Review 9.  The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19.

Authors:  Giuseppe Cerullo; Massimo Negro; Mauro Parimbelli; Michela Pecoraro; Simone Perna; Giorgio Liguori; Mariangela Rondanelli; Hellas Cena; Giuseppe D'Antona
Journal:  Front Immunol       Date:  2020-10-28       Impact factor: 7.561

10.  Leukocytosis and alteration of hemoglobin level in patients with severe COVID-19: Association of leukocytosis with mortality.

Authors:  Babak Sayad; Zeinab Mohseni Afshar; Feizollah Mansouri; Zohreh Rahimi
Journal:  Health Sci Rep       Date:  2020-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.